Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AMG 340 |
Synonyms | |
Therapy Description |
Limited information is currently available on AMG 340, a putative bispecific antibody targeting PSMA and CD3 (May 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMG 340 | AMG-340|AMG340|TNB-585|TNB 585 | CD3 Antibody 85 PSMA Antibody 18 | Limited information is currently available on AMG 340, a putative bispecific antibody targeting PSMA and CD3 (May 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04740034 | Phase I | AMG 340 | A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma | Recruiting | USA | 0 |